-
1
-
-
0027406191
-
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
-
Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
-
(1993)
Diabetes Care
, vol.16
, pp. 434-444
-
-
Stamler, J.1
Vaccaro, O.2
Neaton, J.D.3
Wentworth, D.4
-
2
-
-
0029857628
-
Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: The Munich General Practitioner Project
-
Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hormann A, Holle R. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: The Munich General Practitioner Project. Diabetologia 1996; 39: 1540-5.
-
(1996)
Diabetologia
, vol.39
, pp. 1540-1545
-
-
Standl, E.1
Balletshofer, B.2
Dahl, B.3
Weichenhain, B.4
Stiegler, H.5
Hormann, A.6
Holle, R.7
-
3
-
-
0027438822
-
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris The ECAT Angina Pectoris Study Group
-
Juhan-Vague I, Thompson SG, Jespersen J. Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. Arterioscler Thromb 1993; 13: 1865-73.
-
(1993)
Arterioscler Thromb
, vol.13
, pp. 1865-1873
-
-
Juhan-Vague, I.1
Thompson, S.G.2
Jespersen, J.3
-
4
-
-
0021322084
-
Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
-
Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-60.
-
(1984)
N Engl J Med
, vol.310
, pp. 356-360
-
-
Mogensen, C.E.1
-
5
-
-
0033021172
-
Pathophysiology and clinical significance of atherosclerotic plaque rupture
-
Gutstein DE, Fuster V. Pathophysiology and clinical significance of atherosclerotic plaque rupture. Cardiovasc Res 1999; 41: 323-33.
-
(1999)
Cardiovasc Res
, vol.41
, pp. 323-333
-
-
Gutstein, D.E.1
Fuster, V.2
-
6
-
-
0031943082
-
Haemostatic risk factors for cardiovascular diseases
-
Koenig W. Haemostatic risk factors for cardiovascular diseases. Eur Heart J 1998; 19: C39-43.
-
(1998)
Eur Heart J
, vol.19
-
-
Koenig, W.1
-
7
-
-
0033580591
-
Thrombogenic factors and recurrent coronary events
-
Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, Greenberg H, Weiss HJ, Zareba W, Brown MW, Liang CS, Lichstein E, Little WC, Gillespie JA, Van Voorhees L, Krone RJ, Bodenheimer MM, Hochman J, Dwyer Jr EM, Arora R, Marcus FI, Watelet LF, Case RB. Thrombogenic factors and recurrent coronary events. Circulation 1999; 99: 2517-22.
-
(1999)
Circulation
, vol.99
, pp. 2517-2522
-
-
Moss, A.J.1
Goldstein, R.E.2
Marder, V.J.3
Sparks, C.E.4
Oakes, D.5
Greenberg, H.6
Weiss, H.J.7
Zareba, W.8
Brown, M.W.9
Liang, C.S.10
Lichstein, E.11
Little, W.C.12
Gillespie, J.A.13
Van Voorhees, L.14
Krone, R.J.15
Bodenheimer, M.M.16
Hochman, J.17
Dwyer Jr., E.M.18
Arora, R.19
Marcus, F.I.20
Watelet, L.F.21
Case, R.B.22
more..
-
8
-
-
0037414074
-
Atherothrombosis, inflammation, and diabetes
-
Biondi-Zoccai GG, Abbate A, Liuzzo G, Biasucci LM. Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol 2003; 41: 1071-7.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 1071-1077
-
-
Biondi-Zoccai, G.G.1
Abbate, A.2
Liuzzo, G.3
Biasucci, L.M.4
-
9
-
-
0035093810
-
Diabetes mellitus: A hypercoagulable state
-
Carr ME. Diabetes mellitus: A hypercoagulable state. J Diabet Complications 2001; 15: 44-54.
-
(2001)
J Diabet Complications
, vol.15
, pp. 44-54
-
-
Carr, M.E.1
-
10
-
-
0033663270
-
Dyslipidaemia and coagulation defects of insulin resistance
-
Frohlich J, Steiner G. Dyslipidaemia and coagulation defects of insulin resistance. Int J Clin Pract 2000; 113: 14-22.
-
(2000)
Int J Clin Pract
, vol.113
, pp. 14-22
-
-
Frohlich, J.1
Steiner, G.2
-
11
-
-
0842285784
-
Clinical management of metabolic syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management
-
Grundy SM, Hansen B, Smith Jr SC, Cleeman JI, Kahn RA. Clinical management of metabolic syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004; 109: 551-6.
-
(2004)
Circulation
, vol.109
, pp. 551-556
-
-
Grundy, S.M.1
Hansen, B.2
Smith Jr., S.C.3
Cleeman, J.I.4
Kahn, R.A.5
-
12
-
-
17544403857
-
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: Pathogenesis of atherosclerosis in diabetes
-
Eckel RH, Wassef M, Chait A, Sobel B, Barrett E, King G, Lopes-Virella M, Reusch J, Ruderman N, Steiner G, Vlassara H. Prevention Conference VI: DiabetesPand Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation 2002; 105: E138-43.
-
(2002)
Circulation
, vol.105
-
-
Eckel, R.H.1
Wassef, M.2
Chait, A.3
Sobel, B.4
Barrett, E.5
King, G.6
Lopes-Virella, M.7
Reusch, J.8
Ruderman, N.9
Steiner, G.10
Vlassara, H.11
-
13
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
-
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
-
(1972)
Clin Chem
, vol.18
, pp. 499-502
-
-
Friedewald, W.T.1
Levy, R.I.2
Fredrickson, D.S.3
-
14
-
-
0030761061
-
Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: A prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus
-
Reverter JL, Reverter JC, Tassies D, Rius F, Monteagudo J, Rubies-Prat J, Escolar G, Ordinas A, Sanmarti A. Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: A prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus. Am J Hematol 1997; 56: 93-9.
-
(1997)
Am J Hematol
, vol.56
, pp. 93-99
-
-
Reverter, J.L.1
Reverter, J.C.2
Tassies, D.3
Rius, F.4
Monteagudo, J.5
Rubies-Prat, J.6
Escolar, G.7
Ordinas, A.8
Sanmarti, A.9
-
15
-
-
3042844033
-
Increased expression of tissue factor and receptor for advanced glycation end products in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus with vascular complications
-
Buchs AE, Kornberg A, Zahavi M, Aharoni D, Zarfati C, Rapoport MJ. Increased expression of tissue factor and receptor for advanced glycation end products in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus with vascular complications. Exp Diabesity Res 2004; 5: 163-9.
-
(2004)
Exp Diabesity Res
, vol.5
, pp. 163-169
-
-
Buchs, A.E.1
Kornberg, A.2
Zahavi, M.3
Aharoni, D.4
Zarfati, C.5
Rapoport, M.J.6
-
16
-
-
0037027467
-
Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus
-
Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, Radder JK. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002; 106: 2442-7.
-
(2002)
Circulation
, vol.106
, pp. 2442-2447
-
-
Diamant, M.1
Nieuwland, R.2
Pablo, R.F.3
Sturk, A.4
Smit, J.W.5
Radder, J.K.6
-
17
-
-
0037465510
-
Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity
-
Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, Crandall J, Badimon JJ. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 2003; 107: 973-7.
-
(2003)
Circulation
, vol.107
, pp. 973-977
-
-
Sambola, A.1
Osende, J.2
Hathcock, J.3
Degen, M.4
Nemerson, Y.5
Fuster, V.6
Crandall, J.7
Badimon, J.J.8
-
18
-
-
8544228322
-
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus
-
Zumbach M, Hofmann M, Borcea V, Luther T, Kotzsch M, Muller M, Hergesell O, Andrassy K, Ritz E, Ziegler R, Wahl P, Nawroth PP. Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes 1997; 105: 206-12.
-
(1997)
Exp Clin Endocrinol Diabetes
, vol.105
, pp. 206-212
-
-
Zumbach, M.1
Hofmann, M.2
Borcea, V.3
Luther, T.4
Kotzsch, M.5
Muller, M.6
Hergesell, O.7
Andrassy, K.8
Ritz, E.9
Ziegler, R.10
Wahl, P.11
Nawroth, P.P.12
-
19
-
-
2642522886
-
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: Relationships to cardiovascular disease and risk factor intervention
-
Lim HS, Blann AD, Lip GY. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: Relationships to cardiovascular disease and risk factor intervention. Circulation 2004; 109: 2524-8.
-
(2004)
Circulation
, vol.109
, pp. 2524-2528
-
-
Lim, H.S.1
Blann, A.D.2
Lip, G.Y.3
-
20
-
-
0036250399
-
Evolving role of tissue factor and its pathway inhibitor
-
Doshi SN, Marmur JD. Evolving role of tissue factor and its pathway inhibitor. Crit Care Med 2002; 30: S241-50.
-
(2002)
Crit Care Med
, vol.30
-
-
Doshi, S.N.1
Marmur, J.D.2
-
21
-
-
0031202804
-
Plasma tissue factor reflects endothelial cell injury rather than upregulation of tissue factor expression
-
Koyama T, Ohdama S, Aoki N. Plasma tissue factor reflects endothelial cell injury rather than upregulation of tissue factor expression. Thromb Haemost 1997; 78: 972.
-
(1997)
Thromb Haemost
, vol.78
, pp. 972
-
-
Koyama, T.1
Ohdama, S.2
Aoki, N.3
-
22
-
-
0031701824
-
Endothelial dysfunction in critically ill patients: The effect of haemofiltration
-
Cardigan R, McGloin H, Mackie I, Machin S, Singer M. Endothelial dysfunction in critically ill patients: The effect of haemofiltration. Intensive Care Med 1998; 24: 1264-71.
-
(1998)
Intensive Care Med
, vol.24
, pp. 1264-1271
-
-
Cardigan, R.1
McGloin, H.2
Mackie, I.3
Machin, S.4
Singer, M.5
-
23
-
-
1642315914
-
Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor
-
Makin AJ, Blann AD, Chung NA, Silverman SH, Lip GY. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. Eur Heart J 2004; 25: 371-6.
-
(2004)
Eur Heart J
, vol.25
, pp. 371-376
-
-
Makin, A.J.1
Blann, A.D.2
Chung, N.A.3
Silverman, S.H.4
Lip, G.Y.5
-
24
-
-
2942517677
-
Role of tissue factor in hemostasis, thrombosis, and vascular development
-
Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24: 1015-22.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 1015-1022
-
-
Mackman, N.1
-
25
-
-
0037362704
-
Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets
-
Muller I, Klocke A, Alex M, Kotzsch M, Luther T, Morgenstern E, Zieseniss S, Zahler S, Preissner K, Engelmann B. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003; 17: 476-8.
-
(2003)
FASEB J
, vol.17
, pp. 476-478
-
-
Muller, I.1
Klocke, A.2
Alex, M.3
Kotzsch, M.4
Luther, T.5
Morgenstern, E.6
Zieseniss, S.7
Zahler, S.8
Preissner, K.9
Engelmann, B.10
-
26
-
-
0036799775
-
Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse
-
Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002; 8: 1175-81.
-
(2002)
Nat Med
, vol.8
, pp. 1175-1181
-
-
Falati, S.1
Gross, P.2
Merrill-Skoloff, G.3
Furie, B.C.4
Furie, B.5
-
27
-
-
15944404600
-
Tissue factor activity in whole blood
-
Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG. Tissue factor activity in whole blood. Blood 2005; 105: 2764-70.
-
(2005)
Blood
, vol.105
, pp. 2764-2770
-
-
Butenas, S.1
Bouchard, B.A.2
Brummel-Ziedins, K.E.3
Parhami-Seren, B.4
Mann, K.G.5
-
28
-
-
1642334670
-
Plasma levels of tissue factor antigen in patients with non-insulin-dependent diabetes mellitus
-
Song KS, Kim HK. Plasma levels of tissue factor antigen in patients with non-insulin-dependent diabetes mellitus. Yonsei Med J 2004; 45: 38-42.
-
(2004)
Yonsei Med J
, vol.45
, pp. 38-42
-
-
Song, K.S.1
Kim, H.K.2
-
29
-
-
1842610934
-
Hypofibrinolysis in the insulin resistance syndrome: Implication in cardiovascular diseases
-
Mavri A, Alessi MC, Juhan-Vague I. Hypofibrinolysis in the insulin resistance syndrome: Implication in cardiovascular diseases. J Intern Med 2004; 255: 448-56.
-
(2004)
J Intern Med
, vol.255
, pp. 448-456
-
-
Mavri, A.1
Alessi, M.C.2
Juhan-Vague, I.3
-
30
-
-
19744362790
-
"Vasocrine" signalling from perivascular fat: A mechanism linking insulin resistance to vascular disease
-
Yudkin JS, Eringa E, Stehouwer CD. "Vasocrine" signalling from perivascular fat: A mechanism linking insulin resistance to vascular disease. Lancet 2005; 365: 1817-20.
-
(2005)
Lancet
, vol.365
, pp. 1817-1820
-
-
Yudkin, J.S.1
Eringa, E.2
Stehouwer, C.D.3
-
31
-
-
0842333094
-
Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes
-
Sommeijer DW, MacGillavry MR, Meijers JC, Van Zanten AP, Reitsma PH, Ten Cate H. Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes. Diabetes Care 2004; 27: 468-73.
-
(2004)
Diabetes Care
, vol.27
, pp. 468-473
-
-
Sommeijer, D.W.1
MacGillavry, M.R.2
Meijers, J.C.3
Van Zanten, A.P.4
Reitsma, P.H.5
Ten Cate, H.6
-
33
-
-
0036776063
-
In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins
-
Bombeli T, Jutzi M, De Conno E, Seifert B, Fehr J. In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins. Blood Coagul Fibrinolysis 2002; 13: 577-81.
-
(2002)
Blood Coagul Fibrinolysis
, vol.13
, pp. 577-581
-
-
Bombeli, T.1
Jutzi, M.2
De Conno, E.3
Seifert, B.4
Fehr, J.5
-
34
-
-
0022830171
-
Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study
-
Breddin HK, Krzywanek HJ, Althoff P, Kirchmaier CM, Rosak C, Schepping M, Weichert W, Ziemen M, Schoffling K, Uberla K. Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study. Int Angiol 1986; 5: 181-95.
-
(1986)
Int Angiol
, vol.5
, pp. 181-195
-
-
Breddin, H.K.1
Krzywanek, H.J.2
Althoff, P.3
Kirchmaier, C.M.4
Rosak, C.5
Schepping, M.6
Weichert, W.7
Ziemen, M.8
Schoffling, K.9
Uberla, K.10
-
35
-
-
0034682644
-
Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
-
Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 2000; 133: 81-91.
-
(2000)
Ann Intern Med
, vol.133
, pp. 81-91
-
-
Saito, I.1
Folsom, A.R.2
Brancati, F.L.3
Duncan, B.B.4
Chambless, L.E.5
McGovern, P.G.6
-
36
-
-
18544397868
-
von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: The Hoorn Study
-
Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: The Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 3071-8.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 3071-3078
-
-
Jager, A.1
van Hinsbergh, V.W.2
Kostense, P.J.3
Emeis, J.J.4
Yudkin, J.S.5
Nijpels, G.6
Dekker, J.M.7
Heine, R.J.8
Bouter, L.M.9
Stehouwer, C.D.10
-
37
-
-
0042821646
-
Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis
-
Hocher B, Ziebig R, Altermann C, Krause R, Asmus G, Richter CM, Slowinski T, Sinha P, Neumayer HH. Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis. J Am Soc Nephrol 2003; 14: 2329-37.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 2329-2337
-
-
Hocher, B.1
Ziebig, R.2
Altermann, C.3
Krause, R.4
Asmus, G.5
Richter, C.M.6
Slowinski, T.7
Sinha, P.8
Neumayer, H.H.9
-
38
-
-
0033956187
-
Dermatan sulphate, heparin cofactor II, and F1 + 2 peptide in non-insulin-dependent diabetes mellitus
-
Mascia F, Paoletti P, Mameli G, Mamusa AM, Cirillo R, Marongiu F. Dermatan sulphate, heparin cofactor II, and F1+ 2 peptide in non-insulin-dependent diabetes mellitus. Thromb Res 2000; 97: 263-5.
-
(2000)
Thromb Res
, vol.97
, pp. 263-265
-
-
Mascia, F.1
Paoletti, P.2
Mameli, G.3
Mamusa, A.M.4
Cirillo, R.5
Marongiu, F.6
-
39
-
-
0036676812
-
Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes
-
Leurs PB, Stolk RP, Hamulyak K, Van Oerle R, Grobbee DE, Wolffenbuttel BH. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes. Diabetes Care 2002; 25: 1340-5.
-
(2002)
Diabetes Care
, vol.25
, pp. 1340-1345
-
-
Leurs, P.B.1
Stolk, R.P.2
Hamulyak, K.3
Van Oerle, R.4
Grobbee, D.E.5
Wolffenbuttel, B.H.6
|